CDC posted a forecast for a Funding Opportunity Notice on February 3, 2020 on https://www.grants.gov that funds will be available for FY 2020 to implement their “Behavioral Risk Factor Surveillance System (BRFSS): Impact in Population Health”. (more…)
The “Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) is a joint venture between NIH, FDA, industry partners (Celgene, GSK, Pfizer, Sanofi, and Verily), and one non-profit organization (The Michael J. Fox Foundation for Parkinson’s Research MHFF) managed through the Foundations for NIH (FNIH). (more…)
Senator Sheldon Whitehouse (D-RI) https://whitehouse.senate.gov has introduced “The Patient Safety Improvement Act”. A previous version of the Act was introduced in 2016. The legislation seeks to reduce Healthcare Associated Infections” (HAI) and preserve the effectiveness of existing antibiotics. (more…)
Market research from the International Trade Administration https://www.trade.gov/research-country, shows that over 8% of medical equipment expenditures in Portugal are made by the public sector while 20% of sales are made to the private sector. The market for medical equipment has improved in recent years and is expected to increase opportunities for exporters in the U.S.
CDC recommends telehealth visits to prepare for the possibility of a bigger outbreak of the coronavirus, which could impact encounters in direct to consumer telehealth systems. The impact will depend on the severity of the coronavirus which may result in accelerating investments in remote care systems and services. (more…)
Personalized medicine is an evolving field where physicians use diagnostic tests to determine which medical treatments will work best for each patient. By combining data from tests with an individual’s medical history, circumstances, and values, healthcare providers can develop targeted treatments and prevention plans. (more…)